{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:11:12Z","timestamp":1785435072553,"version":"3.56.0"},"reference-count":84,"publisher":"Akademiai Kiado Zrt.","issue":"48","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:p>A mucormycosis mind a mai napig a legagressz\u00edvabb form\u00e1ban terjed\u0151 gomb\u00e1s\n                    betegs\u00e9g az emberben. A legnagyobb sz\u00e1mban jelenleg is a <jats:italic>Rhizopus,\n                        Lichtheimia<\/jats:italic> \u00e9s <jats:italic>Mucor<\/jats:italic> gombafajt\u00e1k felel\u0151sek a\n                    megbeteged\u00e9sek kialakul\u00e1s\u00e1\u00e9rt. A sz\u00f6vettani mintav\u00e9tel el\u00e9r\u00e9se sok esetben\n                    neh\u00e9zkes, emiatt a megl\u00e9v\u0151 adatok nem informat\u00edvak, a rizik\u00f3faktorok jelenl\u00e9te\n                    mellett a mucormycosis prevalenci\u00e1ja j\u00f3val nagyobbnak t\u0171nik. Az id\u0151 folyam\u00e1n a\n                    besorol\u00e1si rendszerek, kivizsg\u00e1l\u00e1si protokollok, gy\u00f3gyszeres, illetve seb\u00e9szi\n                    kezel\u00e9si m\u00f3dszerek fejl\u0151dtek, azonban fontos kiemelni, hogy a cukorbetegs\u00e9g \u00e9s\n                    az ezzel j\u00e1r\u00f3 ketoacidosisok sz\u00e1m\u00e1nak folyamatos n\u00f6veked\u00e9se, a\n                    COVID\u201319-j\u00e1rv\u00e1nyok ism\u00e9tl\u0151d\u00e9se eln\u00e9pesed\u0151 t\u00e1rsadalmunkban kedvezett a\n                    mucormycosis, illetve ezen bel\u00fcl az orrmell\u00e9k\u00fcregeket is \u00e9rint\u0151\n                    rhinoorbitocerebralis mucormycosis elterjed\u00e9s\u00e9nek. A k\u00f6zlem\u00e9ny c\u00e9lja a betegs\u00e9g\n                    r\u00e9szletes bemutat\u00e1sa, melynek hat\u00e9kony kezel\u00e9se sok esetben a pontos,\n                    mihamarabbi diagn\u00f3zis fel\u00e1ll\u00edt\u00e1s\u00e1t\u00f3l a c\u00e9lzott, gy\u00f3gyszeres ter\u00e1pi\u00e1val a sok\n                    esetben agressz\u00edv szeml\u00e9let\u0171 seb\u00e9szi d\u00e9bridement-en kereszt\u00fcl vezet. Orv Hetil.\n                    2024; 165(48): 1878\u20131887.<\/jats:p>","DOI":"10.1556\/650.2024.33167","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T08:42:12Z","timestamp":1733042532000},"page":"1878-1887","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.2","source":"Crossref","is-referenced-by-count":1,"title":["Az orrmell\u00e9k\u00fcregek mucormycosisa"],"prefix":"10.1556","volume":"165","author":[{"given":"Zolt\u00e1n","family":"Iszlai","sequence":"first","affiliation":[{"name":"Miskolci Egyetem, Eg\u00e9szs\u00e9gtudom\u00e1nyi Kar Miskolc, Szentp\u00e9teri kapu 72\u201376., 3526 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em\u0151ke","family":"Kiss-T\u00f3th","sequence":"additional","affiliation":[{"name":"Miskolci Egyetem, Eg\u00e9szs\u00e9gtudom\u00e1nyi Kar Miskolc, Szentp\u00e9teri kapu 72\u201376., 3526 Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s","family":"Karosi","sequence":"additional","affiliation":[{"name":"Borsod-Aba\u00faj-Zempl\u00e9n V\u00e1rmegyei K\u00f6zponti K\u00f3rh\u00e1z \u00e9s Egyetemi Oktat\u00f3k\u00f3rh\u00e1z, F\u00fcl-orr-g\u00e9g\u00e9szeti \u00e9s Fej-nyakseb\u00e9szeti Oszt\u00e1ly Miskolc Magyarorsz\u00e1g"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.aambs.2019.10.003","article-title":"Detection of the 'big five' mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and mucormycetes","volume":"110","author":"1 Thornton","year":"2020","unstructured":"1 Thornton CR. Detection of the 'big five' mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and mucormycetes. Adv Appl Microbiol. 2020; 110: 1-61.","journal-title":"Adv Appl Microbiol"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2 F\u00fcrbringer P. Observations on pulmonary mucormycosis in humans. [Beobachtungen \u00fcber Lungenmycose beim Menschen.] Virchows Arch Pathol Anat. 1876; 66: 330-365. [German]","DOI":"10.1515\/9783112398760-027"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3 Paltauf A. Mycosis mucorina. A contribution to the knowledge of mycotic diseases. [Mycosis mucorina. Ein Beitrag zur Kenntnis der menschlichen Fadenpiltzer-krankungen.] Virchows Arch Pathol Anat. 1885; 102: 543-564. [German]","DOI":"10.1515\/9783112390382-025"},{"key":"ref3","unstructured":"4 Bhandari J, Thada PK, Nagalli S. Rhinocerebral mucormycosis. 2024 Jan. [Updated 2023 Sep 15.] In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559288\/ [accessed: June 10, 2024]."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"102557","DOI":"10.1016\/j.tmaid.2023.102557","article-title":"Surge of mucormycosis during the COVID-19 pandemic","volume":"52","author":"5 Dam","year":"2023","unstructured":"5 Dam P, Cardoso MH, Mandal S, et al. Surge of mucormycosis during the COVID-19 pandemic. Travel Med Infect Dis. 2023; 52: 102557.","journal-title":"Travel Med Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash H","year":"2019","unstructured":"6 Prakash H, Chakrabarti A. Global epidemiology of mucormycosis. J Fungi (Basel) 2019; 5: 26.","journal-title":"J Fungi (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment","volume":"57","author":"7 Prakash","year":"2019","unstructured":"7 Prakash H, Ghosh KA, Rudramurthy SM, et al. A prospective multicenter study on mucormycosis in India: epidemiology, diagnosis, and treatment. Med Mycol. 2019; 57: 395-402.","journal-title":"Med Mycol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"8 Jeong","year":"2019","unstructured":"8 Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019; 25: 26-34.","journal-title":"Clin Microbiol Infect"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) working group on zygomycosis between 2005 and 2007","volume":"17","author":"9 Skiada","year":"2011","unstructured":"9 Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) working group on zygomycosis between 2005 and 2007. Clin Microbiol Infect. 2011; 17: 1859-1867.","journal-title":"Clin Microbiol Infect"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.mycmed.2018.02.014","article-title":"Mucormycosis in Iran, a six-year retrospective experience","volume":"28","author":"10 Dolatabadi","year":"2018","unstructured":"10 Dolatabadi S, Ahmadi B, Rezaei-Matehkolaei A, et al. Mucormycosis in Iran, a six-year retrospective experience. J Mycol Med. 2018; 28: 269-273.","journal-title":"J Mycol Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases - estimate precision","volume":"3","author":"11 Bongomin","year":"2017","unstructured":"11 Bongomin F, Gago S, Oladele RO, et al. Global and multi-national prevalence of fungal diseases - estimate precision. J Fungi (Basel) 2017; 3: 57.","journal-title":"J Fungi (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12281-023-00464-2","article-title":"Epidemiology of COVID-19-associated mucormycosis","volume":"3","author":"12 Tayabali","year":"2023","unstructured":"12 Tayabali K, Pothiwalla H, Narayanan S. Epidemiology of COVID-19-associated mucormycosis. Curr Fungal Infect Rep. 2023; 3: 1-20.","journal-title":"Curr Fungal Infect Rep"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13 Hassan MIA, Voigt K. Pathogenicity patterns of mucormycosis: epidemiology, interaction with immune cells and virulence factors. Med Mycol. 2019; 57(Suppl 2): S245-S256.","DOI":"10.1093\/mmy\/myz011"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/1469-0691.12566","article-title":"From the pathogens to the disease","volume":"20","author":"14 Binder","year":"2014","unstructured":"14 Binder U, Maurer E, Lass-Fl\u00f6rl C. Mucormycosis. From the pathogens to the disease. Clin Microbiol Infect. 2014; 20: 60-66.","journal-title":"Clin Microbiol Infect"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"15 Roden","year":"2005","unstructured":"15 Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41: 634-653.","journal-title":"Clin Infect Dis"},{"key":"ref15","unstructured":"16 Pagano L, Offidani M, Fianchi L, et al. Mucormycosis in hematologic patients. Haematologica 2004; 89: 207-214."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/jac\/dkp430","article-title":"Forty-one recent cases of invasive zygomycosis from a global clinical registry","volume":"65","author":"17 Rueping","year":"2010","unstructured":"17 Rueping MJ, Heinz WJ, Kindo AJ, et al. Forty-one recent cases of invasive zygomycosis from a global clinical registry. J Antimicrob Chemother. 2010; 65: 296-302.","journal-title":"J Antimicrob Chemother"},{"key":"ref17","unstructured":"18 Csomor J, Nikolova R, Sink\u00f3 J, et al. Mucormycosis. [Mucormycosis.] Orv Hetil. 2004; 145: 2507-2513. [Hungarian]"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00005373-199201000-00003","article-title":"Mucormycosis in trauma patients","volume":"32","author":"19 Cocanour","year":"1992","unstructured":"19 Cocanour CS, Miller-Crotcett P, Reed RL 2nd, et al. Mucormycosis in trauma patients. J Trauma 1992; 32: 12-15.","journal-title":"J Trauma"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1128\/CMR.18.3.556-569.2005","article-title":"Novel perspectives on mucormycosis: pathophysiology, presentation, and management","volume":"18","author":"20 Spellberg","year":"2005","unstructured":"20 Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005; 18: 556-569.","journal-title":"Clin Microbiol Rev"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/ta.0b013e31820784ff","article-title":"Survival of a patient with trauma-induced mucormycosis using an aggressive surgical and medical approach","volume":"70","author":"21 Van Sickels","year":"2011","unstructured":"21 Van Sickels N, Hoffman J, Stuke L, et al. Survival of a patient with trauma-induced mucormycosis using an aggressive surgical and medical approach. J Trauma 2011; 70: 507-509.","journal-title":"J Trauma"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.7205\/MILMED-D-11-00364","article-title":"Invasive fungal infections following combat-related injury","volume":"177","author":"22 Paolino","year":"2012","unstructured":"22 Paolino KM, Henry JA, Hospenthal DR, et al. Invasive fungal infections following combat-related injury. Mil Med. 2012; 177: 681-885.","journal-title":"Mil Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1128\/JCM.00797-09","article-title":"kuwaitiensis infection following combat trauma","volume":"47","author":"23 Tully","year":"2009","unstructured":"23 Tully CC, Romanelli AM, Sutton DA, et al. Fatal Actinomucor elegans var. kuwaitiensis infection following combat trauma. J Clin Microbiol. 2009; 47: 3394-3399.","journal-title":"J Clin Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24 Boelaert JR, de Locht de M, van Cutsem JV, et al. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest. 1993; 91: 1979-1986.","DOI":"10.1172\/JCI116419"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12223-021-00934-5","article-title":"Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic","volume":"67","author":"Sharma A","year":"2022","unstructured":"25 Sharma A, Goel A. Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiol. 2022; 67: 363-387.","journal-title":"Folia Microbiol"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26 Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis. 2012; 54(Suppl 1): S8-S15.","DOI":"10.1093\/cid\/cir864"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27 Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France. The RetroZygo Study (2005-2007). Clin Infect Dis. 2012; 54(Suppl 1): S35-S43.","DOI":"10.1093\/cid\/cir880"},{"key":"ref27","unstructured":"28 DermNet. Mucormycosis pathology. Available from: https:\/\/dermnetnz.org\/topics\/mucormycosis-pathology [accessed: June 20, 2024]."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1288\/00005537-198004000-00010","article-title":"Patient survival factors in paranasal sinus mucormycosis","volume":"90","author":"29 Blitzer","year":"1980","unstructured":"29 Blitzer A, Lawson W, Meyers BR, et al. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980; 90: 635-648.","journal-title":"Laryngoscope"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jcp.13.5.396","article-title":"Tissue reactions to aspergillus in cases of Hodgkin's disease and leukemia","volume":"13","author":"Gowing NF","year":"1960","unstructured":"30 Gowing NF, Hamlin IM. Tissue reactions to aspergillus in cases of Hodgkin's disease and leukemia. J Clin Pathol. 1960; 13: 396-413.","journal-title":"J Clin Pathol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1177\/10668969221099626","article-title":"Histopathological study of mucormycosis in post COVID-19 patients and factors affecting it in a tertiary tare hospital","volume":"31","author":"31 Lakhsmi","year":"2023","unstructured":"31 Lakhsmi IS, Kumari BS, Jyothi C, et al. Histopathological study of mucormycosis in post COVID-19 patients and factors affecting it in a tertiary tare hospital. Int J Surg Pathol. 2023; 31: 56-63.","journal-title":"Int J Surg Pathol"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32 Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012; 54(Suppl 1): S23-S34.","DOI":"10.1093\/cid\/cir866"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1439-0507.2007.01382.x","article-title":"Zygomycosis - a case report and overview of the disease in India","volume":"50","author":"33 Diwakar","year":"2007","unstructured":"33 Diwakar A, Dewan RK, Chowdhary A, et al. Zygomycosis - a case report and overview of the disease in India. Mycoses 2007; 50: 247-254.","journal-title":"Mycoses"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3201\/eid2801.211636","article-title":"Outbreak of mucormycosis in coronavirus disease patients, Pune, India","volume":"28","author":"34 Joshi","year":"2022","unstructured":"34 Joshi S, Telang R, Tambe M, et al. Outbreak of mucormycosis in coronavirus disease patients, Pune, India. Emerng Infect Dis. 2022; 28: 1-8.","journal-title":"Emerng Infect Dis"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1179\/joc.2009.21.3.322","article-title":"Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology)","volume":"21","author":"35 Pagano","year":"2009","unstructured":"35 Pagano L, Valentini CG, Posteraro B, et al. Zygomycosis in Italy: a survey of FIMUA-ECMM (Federazione Italiana di Micopatologia Umana ed Animale and European Confederation of Medical Mycology). J Chemother. 2009; 21: 322-329.","journal-title":"J Chemother"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00405-005-0919-0","article-title":"Rhinocerebral mucormycosis: pathways of spread","volume":"262","author":"Hosseini SM","year":"2005","unstructured":"36 Hosseini SM, Borghei P. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol. 2005; 262: 932-938.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.25259\/SNI_1065_2022","article-title":"Rhinocerebral mucormycosis (RCM): to study the clinical spectrum and outcome of 61 cases of RCM managed at a tertiary care center in India","volume":"14","author":"37 Sharma","year":"2023","unstructured":"37 Sharma AK, Nagarkar NM, Gandhoke CS, et al. Rhinocerebral mucormycosis (RCM): to study the clinical spectrum and outcome of 61 cases of RCM managed at a tertiary care center in India. Surg Neurol Int. 2023; 14: 15.","journal-title":"Surg Neurol Int"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.30699\/ijp.2022.538690.2721","article-title":"The epidemiological, clinical, mycological, and pathological features of rhino-cerebral mucormycosis: a systematic review","volume":"17","author":"38 Salehi","year":"2022","unstructured":"38 Salehi M, Mahmoudi S, Rezahosseini O, et al. The epidemiological, clinical, mycological, and pathological features of rhino-cerebral mucormycosis: a systematic review. Iran J Pathol. 2022; 17: 112-121.","journal-title":"Iran J Pathol"},{"key":"ref38","unstructured":"39 Nithyanandam S, Jacob MS, Battu RR, et al. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol. 2003; 51: 231-236."},{"key":"ref39","unstructured":"40 Mbarek C, Zribi S, Khamassi K, et al. Rhinocerebral mucormycosis: five cases and a literature review. B-ENT 2011; 7: 189-193."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12070-007-0034-1","article-title":"Rhinocerebral mucormycosis: a deadly disease on the rise","volume":"59","author":"41 Mane","year":"2007","unstructured":"41 Mane RS, Watve JK, Mohite AA, et al. Rhinocerebral mucormycosis: a deadly disease on the rise. Indian J Otolaryngol Head Neck Surg. 2007; 59: 112-115.","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1001\/archotol.1997.01900110031005","article-title":"A new classification and diagnostic criteria for invasive fungal sinusitis","volume":"123","author":"42 DeShazo","year":"1997","unstructured":"42 DeShazo RD, O'Brien M, Chapin K, et al. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg. 1997; 123: 1181-1188.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/archotol.124.5.520","article-title":"An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host","volume":"124","author":"43 Gillespie","year":"1998","unstructured":"43 Gillespie MB, O'Malley BW Jr, Francis HW. An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host. Arch Otolaryngol Head Neck Surg. 1998; 124: 520-526.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/2156-7514.184010","article-title":"Sinonasal fungal infections and complications: a pictorial review","volume":"6","author":"44 Gavito-Higuera","year":"2016","unstructured":"44 Gavito-Higuera J, Mullins CB, Ramos-Duran L, et al. Sinonasal fungal infections and complications: a pictorial review. J Clin Imaging Sci. 2016; 6: 23.","journal-title":"J Clin Imaging Sci"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"45 Singh VP, Bansal C, Kaintura M. Sinonasal mucormycosis: A to Z. Indian J Otolaryngol Head Neck Surg. 2019; 71(Suppl 3): 1962-1971.","DOI":"10.1007\/s12070-018-1384-6"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/2229-5178.156393","article-title":"Rhinocerebrocutaneous mucormycosis caused by Mucor species: a rare causation","volume":"6","author":"46 Lunge","year":"2015","unstructured":"46 Lunge SB, Sajjan V, Pandit AM, et al. Rhinocerebrocutaneous mucormycosis caused by Mucor species: a rare causation. Indian Dermatol Online J. 2015; 6: 189-192.","journal-title":"Indian Dermatol Online J"},{"key":"ref46","unstructured":"47 Rhinologic emergencies. Available from: https:\/\/www.thieme-connect.de\/media\/10.1055-b-006-160147\/lookinside\/10-1055-b-006-160147_chapter027-3.jpg [accessed: June 26, 2024]."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3341\/kjo.2008.22.1.66","article-title":"Bilateral ophthalmic artery occlusion in rhino-orbito-cerebral mucormycosis","volume":"22","author":"Song YM","year":"2008","unstructured":"48 Song YM, Shin SY. Bilateral ophthalmic artery occlusion in rhino-orbito-cerebral mucormycosis. Korean J Ophthalmol, 2008; 22: 66-69.","journal-title":"Korean J Ophthalmol"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"49 Lakatos B, Nikolova R, Ocskay L, et al. Case of a diabetes man cured from rhinocerebral zygomycosis. [Rhinocerebralis zygomycosisb\u00f3l gy\u00f3gyult diabeteses f\u00e9rfi esete.] Orv Hetil. 2010; 151: 1591-1596. [Hungarian]","DOI":"10.1556\/oh.2010.28969"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.4103\/jfmpc.jfmpc_1479_21","article-title":"Laboratory diagnosis of mucormycosis: present perspective","volume":"11","author":"50 Gupta","year":"2022","unstructured":"50 Gupta MK, Kumar N, Dhameja N, et al. Laboratory diagnosis of mucormycosis: present perspective. J Family Med Prim Care 2022; 11: 1664-1671.","journal-title":"J Family Med Prim Care"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.4103\/0255-0857.158609","article-title":"Fungal keratitis in North India; spectrum and diagnosis by Calcofluor white stain","volume":"33","author":"51 Gupta","year":"2015","unstructured":"51 Gupta MK, Chandra A, Prakash P, et al. Fungal keratitis in North India; spectrum and diagnosis by Calcofluor white stain. Indian J Med Microbiol. 2015; 33: 462-463.","journal-title":"Indian J Med Microbiol"},{"key":"ref51","unstructured":"52 De Hoog GS, Guarro J, Gene J, et al. Eumycota, zygomycota: explanatory chapter and key to the genera. In: Atlas of Clinical Fungi. Amer Society for Microbiology, Washington, DC, 2000; pp. 58-124."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1099\/jmm.0.000375","article-title":"Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples","volume":"65","author":"53 Springer","year":"2016","unstructured":"53 Springer J, Lackner M, Ensinger C, et al. Clinical evaluation of a Mucorales-specific real-time PCR assay in tissue and serum samples. J Med Microbiol. 2016; 65: 1414-1421.","journal-title":"J Med Microbiol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/jof6040253","article-title":"Comparison of \u03b2-D-glucan and galactomannan in serum for detection of invasive aspergillosis: retrospective analysis with focus on early diagnosis","volume":"6","author":"54 Dichtl","year":"2020","unstructured":"54 Dichtl K, Forster J, Ormanns S, et al. Comparison of \u03b2-D-glucan and galactomannan in serum for detection of invasive aspergillosis: retrospective analysis with focus on early diagnosis. J Fungi 2020; 6: 253.","journal-title":"J Fungi"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ejrnm.2018.01.001","article-title":"Imaging features of rhinocerebral mucormycosis: a study of 43 patients","volume":"49","author":"55 Therakathu","year":"2018","unstructured":"55 Therakathu J, Prabhu S, Irodi A, et al. Imaging features of rhinocerebral mucormycosis: a study of 43 patients. Egypt J Radiol Nucl Med. 2018; 49: 447-452.","journal-title":"Egypt J Radiol Nucl Med"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3174\/ajnr.A4298","article-title":"Acute invasive fungal rhinosinusitis: a comprehensive update of CT findings and design of an effective diagnostic imaging model","volume":"36","author":"56 Middlebrooks","year":"2015","unstructured":"56 Middlebrooks EH, Frost CJ, De Jesus RO, et al. Acute invasive fungal rhinosinusitis: a comprehensive update of CT findings and design of an effective diagnostic imaging model. Am J Neuroradiol. 2015; 36: 1529-1535.","journal-title":"Am J Neuroradiol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1148\/rg.275065189","article-title":"Imaging features of invasive and noninvasive fungal sinusitis: a review","volume":"27","author":"57 Aribandi","year":"2007","unstructured":"57 Aribandi M, McCoy VA, Bazan C. 3rd. Imaging features of invasive and noninvasive fungal sinusitis: a review. RadioGraphics 2007; 27: 1283-1296.","journal-title":"RadioGraphics"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3174\/ajnr.A1808","article-title":"The \"black turbinate\" sign: an early MR imaging finding of nasal mucormycosis","volume":"31","author":"58 Safder","year":"2010","unstructured":"58 Safder S, Carpenter JS, Roberts TD, et al. The \"black turbinate\" sign: an early MR imaging finding of nasal mucormycosis. Am J Neuroradiol. 2010; 31: 771-774.","journal-title":"Am J Neuroradiol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1055\/s-0028-1096209","article-title":"Imaging findings of rhinocerebral mucormycosis","volume":"19","author":"59 Herrera","year":"2009","unstructured":"59 Herrera DA, Dublin AB, Ormsby EL, et al. Imaging findings of rhinocerebral mucormycosis. Skull Base 2009; 19: 117-125.","journal-title":"Skull Base"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"60 Razek AA, Castillo M. Imaging lesions of the cavernous sinus. Am J Neuroradiol. 2009; 30: 444-452. Erratum: Am J Neuroradiol. 2009; 30: E115.","DOI":"10.3174\/ajnr.A1398"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4329\/wjr.v14.i7.209","article-title":"Radiological review of rhinocerebral mucormycosis cases during the COVID-19 pandemic: a single-center experience","volume":"14","author":"61 Saneesh","year":"2022","unstructured":"61 Saneesh PS, Morampudi SC, Yelamanchi R. Radiological review of rhinocerebral mucormycosis cases during the COVID-19 pandemic: a single-center experience. World J Radiol. 2022; 14: 209-218.","journal-title":"World J Radiol"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3174\/ajnr.A0548","article-title":"Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy","volume":"28","author":"62 Luthra","year":"2007","unstructured":"62 Luthra G, Parihar A, Nath K, et al. Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. Am J Neuroradiol. 2007; 28: 1332-1338.","journal-title":"Am J Neuroradiol"},{"key":"ref62","unstructured":"63 Mallis A, Mastronikolis SN, Naxakis SS, et al. Rhinocerebral mucormycosis: an update. Eur Rev Med Pharmacol Sci. 2010; 14: 987-992."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4103\/2152-7806.182964","article-title":"An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis","volume":"7","author":"64 Palejwala","year":"2016","unstructured":"64 Palejwala SK, Zangeneh TT, Goldstein SA, et al. An aggressive multidisciplinary approach reduces mortality in rhinocerebral mucormycosis. Surg Neurol Intern. 2016; 7: 61.","journal-title":"Surg Neurol Intern"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"65 Smith C, Lee SC. Current treatments against mucormycosis and future directions. PLOS Pathogens 2022; 18: e1010858.","DOI":"10.1371\/journal.ppat.1010858"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/jof4030090","article-title":"Therapy of mucormycosis","volume":"4","author":"66 Sipsas","year":"2018","unstructured":"66 Sipsas NV, Gamaletsou MN, Anastasopoulou A, et al. Therapy of mucormycosis. J Fungi 2018; 4: 90.","journal-title":"J Fungi"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1128\/AAC.04435-14","article-title":"Multicenter evaluation of MIC distribution for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales","volume":"59","author":"67 Espinel-Ingroff","year":"2015","unstructured":"67 Espinel-Ingroff A, Chakrabarti A, Chowdhary A, et al. Multicenter evaluation of MIC distribution for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Antimicrob Agents Chemother. 2015; 59: 1745-1750.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1093\/jac\/dkv236","article-title":"Prospective pilot study of high-dose (10 mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis","volume":"70","author":"68 Lanternier","year":"2015","unstructured":"68 Lanternier F, Poiree S, Elie C, et al. Prospective pilot study of high-dose (10 mg\/kg\/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis. J Antimicrob Chemother. 2015; 70: 3116-3123.","journal-title":"J Antimicrob Chemother"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries","volume":"64","author":"69 Rudramurthy","year":"2021","unstructured":"69 Rudramurthy SM, Hoenigl M, Meis JF, et al. ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses 2021; 64: 1028-1037.","journal-title":"Mycoses"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S1473-3099(16)00071-2","article-title":"Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis","volume":"16","author":"70 Marty","year":"2016","unstructured":"70 Marty FM, Ostrosky-Zeichner L, Cornely OA, et al. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. Lancet Infect Dis. 2016; 16: 828-837.","journal-title":"Lancet Infect Dis"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"71 Greenberg","year":"2006","unstructured":"71 Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006; 50: 126-133.","journal-title":"Antimicrob Agents Chemother"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mmcr.2016.03.002","article-title":"Isavuconazole as salvage therapy for mucormycosis","volume":"11","author":"72 Graves","year":"2016","unstructured":"72 Graves B, Morrissey CO, Wei A, et al. Isavuconazole as salvage therapy for mucormycosis. Med Mycol Case Rep. 2016; 11: 36-39.","journal-title":"Med Mycol Case Rep"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/myc.12909","article-title":"Antifungal combinations in mucorales: a microbiological perspective","volume":"62","author":"73 Schwarz","year":"2019","unstructured":"73 Schwarz P, Cornely OA, Dannaoui E. Antifungal combinations in mucorales: a microbiological perspective. Mycoses 2019; 62: 746-760.","journal-title":"Mycoses"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/jac\/dkab233","article-title":"Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis","volume":"76","author":"74 Gebremariam","year":"2021","unstructured":"74 Gebremariam T, Gu Y, Singh S, et al. Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis. J Antimicrob Chemother. 2021; 76: 2636-2639.","journal-title":"J Antimicrob Chemother"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1086\/589857","article-title":"Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis","volume":"47","author":"75 Reed","year":"2008","unstructured":"75 Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008; 47: 364-371.","journal-title":"Clin Infect Dis"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.chom.2019.08.004","article-title":"Calcium-calmodulin-calcineurin signaling: a globally conserved virulence cascade in eukaryotic microbial pathogens","volume":"26","author":"76 Park","year":"2019","unstructured":"76 Park HS, Lee SC, Cardenas ME, et al. Calcium-calmodulin-calcineurin signaling: a globally conserved virulence cascade in eukaryotic microbial pathogens. Cell Host Microbe 2019; 26: 453-462.","journal-title":"Cell Host Microbe"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11908-012-0272-6","article-title":"Rhino-orbital-cerebral mucormycosis","volume":"14","author":"Gamaletsou","year":"2012","unstructured":"77 Gamaletsou, MN, Sipsas NV, Roilides E, et al. Rhino-orbital-cerebral mucormycosis. Curr Infect Dis Rep. 2012; 14: 423-434.","journal-title":"Curr Infect Dis Rep"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"95","DOI":"10.47210\/bjohns.2022.v30i1.608","article-title":"Surgical approach to rhino-orbital mucormycosis using contrast enhanced MRI as roadmap","volume":"30","author":"78 Kar","year":"2022","unstructured":"78 Kar T, Dubey B, Biswas S. Surgical approach to rhino-orbital mucormycosis using contrast enhanced MRI as roadmap. Bengal J Otolaryngol Head Neck Surg. 2022; 30: 95-103.","journal-title":"Bengal J Otolaryngol Head Neck Surg"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"79 Boelaert JR. Mucormycosis (zygomycosis): is there news for the clinician? J Infect. 1994; 28(Suppl 1): 1-6.","DOI":"10.1016\/S0163-4453(94)95896-3"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"80 Yadav RR, Singh V, Siva S, et al. Surgical approaches in rhino-orbito-cerebral mucormycosis. Nat Med Organ J. 2022; 16: 31-39.","DOI":"10.53772\/NMO.2022.16106"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12663-022-01803-5","article-title":"Outcome of open surgery in disease progression of post-COVID rhinomaxillary mucormycosis treated by functional endoscopic sinus surgery and proposed evaluation scale for maxillary sinus disease and osteomyelitis","volume":"22","author":"81 Manekar","year":"2023","unstructured":"81 Manekar VS, Datarkar AN, Karemore S, et al. Outcome of open surgery in disease progression of post-COVID rhinomaxillary mucormycosis treated by functional endoscopic sinus surgery and proposed evaluation scale for maxillary sinus disease and osteomyelitis. J Maxillofac Oral Surg. 2023; 22: 464-469.","journal-title":"J Maxillofac Oral Surg"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00405-021-06910-6","article-title":"Clinical and surgical factors affecting the prognosis and survival rates in patients with mucormycosis","volume":"279","author":"82 G\u00fcr","year":"2022","unstructured":"82 G\u00fcr H, \u0130smi O, Vay\u0131so\u011flu Y, et al. Clinical and surgical factors affecting the prognosis and survival rates in patients with mucormycosis. Eur Arch Otorhinolaryngol. 2022; 279: 1363-1369.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"83 Gode S, Turhal G, Ozturk K, et al. Acute invasive fungal rhinosinusitis: survival analysis and the prognostic indicators. Am J Rhinol Allergy 2015; 29: e164-e169.","DOI":"10.2500\/ajra.2015.29.4245"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00405-008-0692-y","article-title":"Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment","volume":"266","author":"84 Arndt","year":"2009","unstructured":"84 Arndt S, Aschendorff A, Echternach M, et al. Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment. Eur Arch Otorhinolaryngol. 2009; 266: 71-76.","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/165\/48\/article-p1878.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/165\/48\/article-p1878.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/165\/48\/article-p1878.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T09:53:20Z","timestamp":1733997200000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/165\/48\/article-p1878.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":84,"journal-issue":{"issue":"48"},"URL":"https:\/\/doi.org\/10.1556\/650.2024.33167","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}